NCT05719974 is a NA clinical trial of rehabilitation protocol in Knee Ligament Injury, sponsored by Delta University for Science and Technology.

Who is sponsoring NCT05719974?

NCT05719974 is sponsored by Delta University for Science and Technology.

What drugs are being tested in NCT05719974?

Interventions in NCT05719974: rehabilitation protocol.

What condition does NCT05719974 study?

NCT05719974 studies Knee Ligament Injury, Anterior Cruciate Ligament Injuries.

Is NCT05719974 still recruiting?

NCT05719974 is currently completed. Last updated 9 February 2023.

Last reviewed 2023-02-09 · How we verify

NCT05719974

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Functional Outcomes of a Criterion-based Rehabilitation Protocol for ACL Reconstruction in Amateur Athlete

Completed NA Last updated 9 February 2023

What this trial tests

NA trial testing rehabilitation protocol in Knee Ligament Injury in 50 participants. Completed in 7 January 2023.

Timeline

3 March 2020

Primary endpoint
15 June 2022

7 January 2023

Quick facts

Lead sponsor	Delta University for Science and Technology
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	50
Start date	3 March 2020
Primary completion	15 June 2022
Estimated completion	7 January 2023
Sites	1 location across Egypt

Drugs / interventions tested

rehabilitation protocol

Conditions studied

Knee Ligament Injury — all drugs for Knee Ligament Injury →
Anterior Cruciate Ligament Injuries — all drugs for Anterior Cruciate Ligament Injuries →

Sponsor

Delta University for Science and Technology

Who can join

Adults 18 to 35, male only, with Knee Ligament Injury or Anterior Cruciate Ligament Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Although current rehabilitation protocols following anterior cruciate ligament reconstruction (ACLR) are based on the graft remodeling process, there is uncertainty about its time schedule. Moreover, there are individual differences in neuromotor learning and flexibility after ACLR. This study was conducted to investigate the effect of a criterion-based rehabilitation protocol on pain intensity, effusion, and knee function in amateur athletes following ACLR. Although current rehabilitation protocols following anterior cruciate ligament reconstruction (ACLR) are based on the graft remodeling process, there is uncertainty about its time schedule. Moreover, there are individual differences in neuromotor learning and flexibility after ACLR. This study was conducted to investigate the effect of a criterion-based rehabilitation protocol on pain intensity, effusion, and knee function in amateur athletes following ACLR.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of rehabilitation protocol

Trials testing the same drug.

NCT07280429 — ICIAM Rehabilitation Program Study: A Randomized Controlled Trial · NA · not yet recruiting
NCT05716529 — Functional Outcomes of an Accelerated Rehabilitation Protocol for ACL Reconstruction in Amateur Athletes · NA · completed

Other Delta University for Science and Technology trials

Trials by the same sponsor.

NCT07321119 — Correlation Between Cervical Deep Flexors Endurance and Proprioception Function in Cervical Radiculopathy · not yet recruiting
NCT07289607 — Effect of TECAR on Cervical Radiculopathy · NA · not yet recruiting
NCT07292675 — The Effect of Low Intensity With BFR on Stroke Patients · NA · not yet recruiting
NCT07230938 — Effects of Neck Proprioception Impairment on Balance in Cervical Spondylosis Patients · not yet recruiting
NCT07333872 — Evaluation of Pulpotomy, Partial Pulpotomy, and Direct Pulp Capping Using Mineral Trioxide Aggregate. · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05719974 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Delta University for Science and Technology
Last refreshed: 9 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05719974.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing